Skip to main content

Table 3 Comparison between Choi and RECIST criteria at 2 months in the ITT2 population (N = 35)

From: RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study

 

Responders (Choi)

Non-Responders (Choi)

Total

SD (RECIST 1.1)

11

9

20

PD (RECIST 1.1)

7

8

15

Total

18

17

35